BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2416205)

  • 1. On the interaction of beta-adrenoceptor-blocking drugs with isolated mast cells.
    Nosál R; Pecivová J; Drábiková K
    Agents Actions; 1985 Sep; 16(6):478-84. PubMed ID: 2416205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-adrenoceptor blocking drugs on 32P incorporation into and arachidonic acid liberation from phospholipids in stimulated rat mast cells.
    Pecivová J; Drábiková K; Nosál R
    Agents Actions; 1989 Apr; 27(1-2):29-32. PubMed ID: 2568743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor blocking drugs and calcium transport in isolated rat mast cells.
    Drábiková K; Pecivová J; Nosál R
    Agents Actions; 1989 Apr; 27(1-2):33-5. PubMed ID: 2473626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of beta-adrenoceptor blocking drugs on histamine liberation, prostaglandin synthesis and phospholipid turnover in isolated mast cells stimulated with concanavalin A.
    Drábiková K; Pecivová J; Petríková M; Jancinová V; Nosál R
    Agents Actions; 1990 Apr; 30(1-2):77-80. PubMed ID: 1695467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of beta-adrenergic blocking drugs and inhibitors of phosphodiestease on histamine release from isolated mast cells.
    Nosál R; Menyhardtová Z
    Agents Actions; 1977 Jul; 7(2):231-6. PubMed ID: 70989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane perturbing activity of beta-adrenoceptor blocking drugs in isolated rat mast cells.
    Nosál R; Drábiková K; Pecivová J; Ondrias K
    Agents Actions; 1989 Apr; 27(1-2):36-8. PubMed ID: 2473627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the relationship between incorporation of 32P into phospholipids and binding of beta-adrenoceptor blocking drugs to isolated mast cells.
    Pecivová J; Drábiková K; Jancinová V; Nosál R
    Agents Actions; 1988 Apr; 23(3-4):146-8. PubMed ID: 2899380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amine transport in isolated rat mast cells treated with betaadrenoceptor blocking drugs.
    Nosál R; Pecivová J; Drábiková K
    Agents Actions; 1986 Apr; 18(1-2):74-6. PubMed ID: 2873725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of adrenergic beta receptor blockers on phospholipid metabolism in mast cells].
    Pecivová J; Drábiková K; Nosál' R
    Bratisl Lek Listy; 1990 May; 91(5):363-8. PubMed ID: 1974476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of functionally active beta-adrenoceptors in rat mast cells. Correlation between (--)[3H]-dihydroalprenolol binding and inhibition of histamine release.
    Masini E; Fantozzi R; Blandina P; Galli A; Bani-Sacchi T; Giotti A; Zilletti L; Mannaioni PF
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):171-6. PubMed ID: 6185855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine liberation as a result of nonreceptor interaction.
    Nosál R; Drábiková K; Pecivová J; Jakubovský J
    Agents Actions; 1990 Apr; 30(1-2):74-6. PubMed ID: 1695466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of histamine liberation. Cationic amphiphilic drugs and mast cells.
    Nosál R
    J Physiol Pharmacol; 1994 Sep; 45(3):377-86. PubMed ID: 7531010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for intracellular histamine liberation in isolated rat mast cells.
    Nosál R; Pecivova J; Drábiková K
    Agents Actions; 1982 Dec; 12(5-6):601-7. PubMed ID: 6187191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of compound 48/80 on mast cells, histamine, and cyclic AMP in isolated superior cervical ganglia.
    Lindl T; Behrendt H; Heinl-Sawaja MC; Teufel E; Cramer H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 286(3):283-96. PubMed ID: 4142070
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative relationship between histamine and 35S release from isolated rat mast cells due to the beta-adrenoceptor blocking drug Kö 1124.
    Nosál R; Pecivoá J; Drábikova K
    Biochem Pharmacol; 1981 Jun; 30(12):1693-5. PubMed ID: 6168269
    [No Abstract]   [Full Text] [Related]  

  • 16. Atenolol, exaprolol and mast cell membranes.
    Pecivová J; Drábiková K; Jancinová V; Petríková M; Nosál R
    Agents Actions; 1991 May; 33(1-2):41-3. PubMed ID: 1680276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chloroquine on isolated mast cells.
    Nosál R; Drábiková K; Pecivová J
    Agents Actions; 1991 May; 33(1-2):37-40. PubMed ID: 1716835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP independent inhibition by papaverine of histamine release induced by compound 48/80.
    Fredholm BB; Guschin I; Elwin K; Schwab G; Uvnäs B
    Biochem Pharmacol; 1976 Jul; 25(14):1583-8. PubMed ID: 60103
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative correlation between histamine and 35S release from isolated rat mast cells due to the beta-adrenergic blocking drug Kö 1124.
    Nosál R; Pecivová J; Drábiková K
    Agents Actions; 1981 Jul; 11(4):318-23. PubMed ID: 6169261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine liberation and membrane fluidisation of mast cells exposed to the beta-adrenoceptor blocking drug propranolol.
    Nosál R; Ondrias K; Pecivová J; Drábiková K
    Agents Actions; 1988 Apr; 23(3-4):143-5. PubMed ID: 2455973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.